Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Chemmedchem|September 5, 2006
Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agentsJing-Ping Liou, Neeraj Mahindroo, Chun-Wei Chang, et al.Chemical Research in Toxicology|August 15, 2015
Novel Nrf2/ARE activator, trans-Coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38α/MAPKAPK-2 and PK-N3 signaling pathwayHuang-Hui Chen, Tai-Chi Wang, Yen-Chen Lee, et al.RSC Advances|April 7, 2025
Cytotoxicity-guided isolation of elatostemanosides I-VI from Elatostema tenuicaudatum W. T. Wang and their cytotoxic activitiesQuoc-Dung Tran Huynh, Thuy-Tien Thi Phan, Ta-Wei Liu, et al.Theranostics|April 16, 2021
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activationYa-Chu Tang, Jenn-Ren Hsiao, Shih-Sheng Jiang, et al.Journal of Medicinal Chemistry|March 26, 2011
Scaffold-hopping strategy: synthesis and biological evaluation of 5,6-fused bicyclic heteroaromatics to identify orally bioavailable anticancer agentsYen-Shih Tung, Mohane Selvaraj Coumar, Yu-Shan Wu, et al.Journal of Medicinal Chemistry|June 11, 2009
Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activityYi-Kun Chiang, Ching-Chuan Kuo, Yu-Shan Wu, et al.Journal of Medicinal Chemistry|June 14, 2017
Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase InhibitorsTeng-Kuang Yeh, Ching-Chuan Kuo, Yue-Zhi Lee, et al.Pharmacological Research|December 21, 2024
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft modelsYa-Chu Tang, Jing-Jim Ou, Shu-Ching Hsu, et al.Journal of Medicinal Chemistry|January 22, 2020
Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase InhibitorsYi-Hui Peng, Fang-Yu Liao, Chen-Tso Tseng, et al.Journal of Medicinal Chemistry|November 26, 2024
Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological CharacterizationHsin-Huei Chang, Lung-Chun Lee, Tsu Hsu, et al.Pageof 10